ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...

The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal ...

Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...

A combination of two existing chemotherapy drugs has been used to fight bladder cancer successfully for the first time in Singapore. This new union of the two “off-label” drugs – gemcitabine and ...

Eating specific foods and avoiding others may help reduce your risk of gallbladder disease. A gallbladder diet is an overall ...

ImmunityBio, Inc. (NASDAQ:IBRX) released progress in its ongoing FDA discussions regarding three areas of its clinical ...

Researchers from the University of Sheffield and Barts Cancer Institute at Queen Mary, University of London have found that ...

Osteoporosis, breast cancer, even bladder infections are all health conditions we normally associate with women. Yet they can ...

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...

A Keighley deli owner is taking part in clinical trials of a new drug which could transform bladder cancer treatment.

A KEIGHLEY deli owner is taking part in clinical trials of a new drug which could transform bladder cancer treatment.

A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the University ...